Ultrasound (US)-triggered sonodynamic therapy (SDT) that enables noninvasive treatment
of large internal tumors has attracted widespread interest. For improvement in the …

Sonodynamic therapy (SDT), which can generate reactive oxygen species (ROS) based on
sonosensitizers under ultrasound (US) to kill tumor cells, has emerged as a noninvasive …

Sonosensitizers play crucial roles in the controlled production of reactive oxygen species
(ROS) under ultrasound (US) irradiation with high tissue-penetration depth for noninvasive …

Although sonodynamic therapy (SDT) has emerged as a potential alternative to
conventional photodynamic therapy, the low quantum yield of the sonosensitizer such as …

Sonodynamic therapy, with advantages in large tissue penetration depth and great
controllability, is a promising type of non-invasive cancer treatment method. Developing …

Background Sonodynamic therapy (SDT) has emerged as a noninvasive therapeutic
modality that involves sonosensitizers and low-intensity ultrasound. However, owing to the …

The further bioapplications of sonodynamic therapy (SDT) were hindered by the inadequate
efficiency and poor degradability of sonosensitizers and the hypoxic tumor …

Despite the merits of high tissue-penetrating depth, no ionizing radiation, and low cost,
sonodynamic therapy (SDT) still suffers from a low quantum yield of reactive oxygen species …

Reactive oxygen species (ROS) depletion and low ROS production that result from the
intratumoral redox metabolism equilibrium and low energy conversion efficiency from …

Ultrasound (US)‐triggered sonodynamic therapy (SDT), as a promising noninvasive
therapeutic modality, has received ever‐increasing attention in recent years. Its specialized …